Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis

Toxicol Appl Pharmacol. 2014 Jan 1;274(1):87-95. doi: 10.1016/j.taap.2013.10.031. Epub 2013 Nov 6.

Abstract

Cisplatin is an effective anti-cancer drug; however, its clinical use is usually associated with nephrotoxicity as a dose-limiting side effect. Several molecular mechanisms have been found to be involved in this nephrotoxicity such as oxidative stress, inflammation and apoptosis. The aim of this study was to explore the potential nephroprotective effect of cardamonin, a flavone found in Alpinia plant, in a rat model of cisplatin-induced nephrotoxicity. The possible mechanisms underlying this nephroprotective effect were investigated. Cardamonin was given at two different doses; 10 and 30mg/kg orally for two weeks, starting one week before giving a single nephrotoxic dose of cisplatin (7mg/kg). Acute nephrtoxicity was evident by significantly increased blood urea nitrogen and serum creatinine levels. Also, cisplatin increased lipid peroxidation and depleted reduced glutathione level and superoxide dismutase. Additionally, cisplatin showed a marked pro-inflammatory response as evidenced by significant increase in tissue levels of IL-1β, TNF-α, NF-kB, iNOS, ICAM-1 and MCP-1. Pre-treatment with cardamonin significantly attenuated the nephrotoxic effects, oxidative stress and inflammation induced by cisplatin, in a dose-dependent manner. Also, cardamonin decreased caspase-3 expression and Bax/Bcl-2 ratio as compared to cisplatin group. Besides, cradamonin reversed cisplatin-induced decrease in EGF. Furthermore, up-regulation of NOX-1 was found to be involved in cisplatin-induced nephrotoxicity and its expression was significantly reduced by cardamonin. Histopathological examination further confirmed the nephroprotective effect of cardamonin. Moreover, pre-treatment with subtoxic concentration of cardamonin has significantly enhanced cisplatin cytotoxic activity in four different human cancer cell lines; hela, hepG2, PC3 and HCT116 cancer cell lines. In conclusion, these findings suggest that cardamonin improves therapeutic index of cisplatin and that NOX-1 is partially involved in the pathogenesis of cispaltin-induced nephrotoxicity.

Keywords: Apoptosis; Cardamonin; Cisplatin; Inflammation; NOX-1; Nephrotoxicity.

MeSH terms

  • Animals
  • Antineoplastic Agents / toxicity
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Chalcones / administration & dosage*
  • Cisplatin / toxicity*
  • HCT116 Cells
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Inflammation / chemically induced
  • Inflammation / enzymology
  • Inflammation / prevention & control
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology*
  • Male
  • NADH, NADPH Oxidoreductases / biosynthesis*
  • NADPH Oxidase 1
  • Protective Agents / administration & dosage
  • Random Allocation
  • Rats

Substances

  • Antineoplastic Agents
  • Chalcones
  • Protective Agents
  • NADH, NADPH Oxidoreductases
  • NADPH Oxidase 1
  • cardamonin
  • Cisplatin